My Ph.D. took a long time—and there’s no shame in that
“If I didn’t have the answer to my research question yet it was because the answer was complex, not because of personal shortcomings,” this scientist writes
Related Articles
Looking at a sick person in VR can rev up our bodies’ immune systems
New study provides “remarkable” glimpse into how the brain predicts potential infections
Insect X-Men: Helmets help these odd bugs sense electric fields
Ability may help treehoppers distinguish friend from foe
A wearable spatiotemporal controllable ultrasonic device with amyloid-β disaggregation for continuous Alzheimer’s disease therapy
A portable, fully integrated wearable ultrasound system (WUS) promotes amyloid protein depolymerization.
Steering plant-soil feedback for sustainable agriculture
The challenge of producing food at low monetary cost comes with high environmental impacts as yield maximization by excessive fertilization and chemical pest control drive…
New AI model helps historians complete damaged Latin texts
By efficiently filling in Roman inscriptions’ missing characters, the new model promises easier glimpses into the lives of ancient people
Genome-wide study makes ‘quantum leap’ in understanding stuttering
Analysis of DNA from 23andMe users points to variants in genes linked to brain function and sense of rhythm
‘Things keep evolving into anteaters.’ Odd animals arose at least 12 separate times
Findings speak to the dramatic impact ants and termites can have on mammalian evolution
Will your next surgeon be a robot? Autonomy and AI in robotic surgery
Artificial intelligence and robotics are enabling surgical autonomy, with potential to improve outcomes and expand access to care.
Preexisting immunity to the 2009 pandemic H1N1 virus reduces susceptibility to H5N1 infection and disease in ferrets
Prior infection with the 2009 pandemic H1N1 influenza virus confers protection against H5N1 infection and disease in ferrets.
Ofichem Acquires Meribel Pharma Solutions’ Uppsala Site
Ofichem, a Netherlands-based CDMO, acquired Meribel Pharma Solutions’ site in Uppsala, Sweden, to support early-phase, IP-driven drug substance development and to expand its non-GMP capabilities…
